The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria

Molecular Microbiology

Volumn 53, Issue 1, 2004, Pages 275-282

  Rengarajan, Jyothi ^a   Sassetti, Christopher M ^a   Naroditskaya, Vera ^b   Sloutsky, Alexander ^b   Bloom, Barry R ^a   Rubin, Eric J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; BCG VACCINE; FOLIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BACTERIUM MUTANT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; FOLATE METABOLISM; GENE INSERTION; GENE MUTATION; MOLECULAR MECHANICS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYA GENE; TRANSPOSON;

DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FOLIC ACID; FOLIC ACID ANTAGONISTS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; P-AMINOSALICYLIC ACID; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; INSERTION SEQUENCES; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; TRANSPOSONS; UNCULTURED ACTINOMYCETE;

EID: 3142583521     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2004.04120.x     Document Type: Article

References (20)

1. Cersini, A., Salvia, A.M., and Bernardini, M.L. (1998) Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect Immun 66: 549-557.
2. Dye, C., Williams, B.G., Espinal, M.A., and Raviglione, M.C. (2002) Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295: 2042-2046.
3. Finer-Moore, U.S., Santi, D.V., and Stroud, R.M. (2003) Lessons and conclusions from dissecting the mechanism of a bisubstrate enzyme: thymidylate synthase mutagenesis, function, and structure. Biochemistry 42: 248-256.
4. Green, J.M., Nichols, B.P., and Matthews, R.G. (1996) Folate biosynthesis, reduction, and polyglutamation. In Escherichia coli and Salmonella, Vol. 1. Neidhardt, F.C. (ed.). Washington, DC: American Society for Microbiology Press, pp. 665-673.
5. Huovinen, P., Sundstrom, L., Swedberg, G., and Skold, O. (1995) Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 39: 279-289.
6. Iwainsky, H. (1988) Mode of action, biotransformation and pharmacokinetics of antituberculosis drugs in animals and man. In Antituberculosis Drugs. Bartmann, K. (ed.). Berlin: Springer-Verlag, pp. 457-465.
7. Kok, M., Buhlmann, E., and Pechere, J.C. (2001) Salmonella typhimurium thyA mutants fail to grow intracellularly in vitro and are attenuated in mice. Microbiology 147: 727-733.
8. Lehmann, J. (1946) para-Aminosalicylic acid in the treatment of tuberculosis. Lancet i: 15-16.
9. Matsumoto, S., Yukitake, H., Ohara, N., Dairi, T., Kanbara, H., and Yamada, T. (1998) Shotgun cloning and characterization of the thymidylate synthase-encoding gene from Mycobacterium bovis BCG. Microbiol Immunol 42: 15-21.
10. Metchock, B.G., Nolte, F.S., and Wallace, R.J. (1999) Mycobacterium. In Manual of Clinical Microbiology. Murray, P.R. (ed.). Washington, DC: American Society for Microbiology Press, pp. 399-437.
11. Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcantara, F., et al. (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 348: 119-128.
12. Myllykallio, H., Lipowski, G., Leduc, D., Filee, J., Forterre, P., and Liebl, U. (2002) An alternative flavin-dependent mechanism for thymidylate synthesis. Science 297: 105-107.
13. Neuhard, J., and Kelln, R.A. (1996) Biosynthesis and conversions of pyrimidines. In Escherichia coli and Salmonella, Vol. 1. Neidhardt, F.C. (ed.). Washington, DC: American Society for Microbiology Press, pp. 580-600.
14. Nopponpunth, V., Sirawaraporn, W., Greene, P.J., and Santi, D.V. (1999) Cloning and expression of Mycobacterium tuberculosis and Mycobacterium leprae dihydropteroate synthase in Escherichia coli. J Bacteriol 181: 6814-6821.
15. Offe, H. (1988) Historical introduction and chemical characteristics of antituberculosis drugs. In Antituberculosis Drugs. Bartmann, K. (ed.). Berlin: Springer-Verlag, pp. 1-10.
16. Sassetti, C., Boyd, D.H., and Rubin, E.J. (2001) Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci USA 98: 12712-12717.
17. Sassetti, C.M., Boyd, D.H., and Rubin, E.J. (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48: 77-84.
18. Somoskovi, A., Parsons, L.M., and Salfinger, M. (2001) The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res 2: 164-168.
19. Suling, W.J., Reynolds, R.C., Barrow, E.W., Wilson, L.N., Piper, J.R., and Barrow, W.W. (1998) Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase. J Antimicrob Chemother 42: 811-815.
20. Wahba, A.J., and Friedkin, M.J. (1961) Direct spectrophotometric evidence for the oxidation of tetrahydrofolate during the enzymatic synthesis of thymidylate. J Biol Chem 236: 11-12.